Skip to main content
ALLO logo
ALLO
(NASDAQ)
Allogene Therapeutics, Inc.
$2.08-- (--)
Loading... - Market loading

Allogene Therapeutics (ALLO) Stock Price & Financial Analysis

Allogene Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.92 - $2.08
52-Week High$4.46
52-Week Low$0.99
Open$1.96
Volume4.60M
Average Volume (3M)6.86M
Market Cap492.60M
Shares Outstanding240.29M
Price to Book (P/B)1.73
EV/EBITDA-3.20
50-Day MA$1.96
200-Day MA$1.89
52-Week Change93.27%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Allogene Therapeutics

What is the current stock price for ALLO?

As of the latest trading session, ALLO stock trades at $2.05. The 52-week range is $0.99–$4.46, with a day range of $1.92–$2.08.

What is the P/E ratio for ALLO?

The P/E ratio (Price-to-Earnings) for ALLO is shown in the Key Statistics section. This valuation metric helps compare Allogene Therapeutics, Inc. to industry peers.

Does ALLO pay dividends?

Allogene Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALLO?

Based on 1 analyst, the consensus for ALLO is Buy.

What is the market cap of ALLO?

Allogene Therapeutics's market capitalization is $492.6M, classifying it as a small-cap company. Allogene Therapeutics operates in the Healthcare sector within the Biotechnology industry.